Daniel Engelman to Anti-Bacterial Agents
This is a "connection" page, showing publications Daniel Engelman has written about Anti-Bacterial Agents.
Connection Strength
0.769
-
Engelman D, Mataika RL, Kado JH, Ah Kee M, Donath S, Parks T, Steer AC. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji. Trop Med Int Health. 2016 12; 21(12):1583-1591.
Score: 0.342
-
Rwebembera J, Ndagire E, Carvalho N, Webel AR, Sable C, Okello E, Sarnacki R, Spaziani AM, Mucunguzi A, Engelman D, Grobler A, Steer A, Beaton A. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial). Am Heart J. 2024 Sep; 275:74-85.
Score: 0.144
-
Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, Canales L, Carapetis J, DeWyer A, Lwabi P, Mirabel M, Mocumbi AO, Murali M, Nakitto M, Ndagire E, Nunes MCP, Omara IO, Sarnacki R, Scheel A, Wilson N, Zimmerman M, Z?hlke L, Karthikeyan G, Sable CA, Steer AC. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease. N Engl J Med. 2022 01 20; 386(3):230-240.
Score: 0.121
-
Beaton A, Okello E, Engelman D, Grobler A, Scheel A, DeWyer A, Sarnacki R, Omara IO, Rwebembera J, Sable C, Steer A. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial. Am Heart J. 2019 09; 215:95-105.
Score: 0.102
-
Nascimento BR, Nunes MCP, da Silva JLP, Steer A, Engelman D, Okello E, Rwebembera J, Zuhlke L, Mirabel M, Nakitto M, Sarnacki R, Ribeiro ALP, Sable CA, Beaton AZ. Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis. Int J Cardiol. 2024 Mar 15; 399:131662.
Score: 0.035
-
Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Steer AC, Kaldor JM. Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial. Lancet Glob Health. 2018 10; 6(10):e1132-e1138.
Score: 0.024